HEMEL HEMPSTEAD, England—Thermo Fisher Scientific Inc. announced in July a collaboration with the integrative network biology initiative at The Institute of Cancer Research (ICR). The collaboration involves a number of Thermo Fisher Scientific solutions, including laboratory equipment, silencing RNA, protein reagents, mass spectrometry and related services. The ICR's new, state-of-the-art proteomics laboratory has been equipped with a complete Thermo Scientific proteomics workflow, including the Kingfisher Flex automated sample preparation system, the TSQ Vantage triple quadrupole and the UK's first two LTQ Orbitrap Velos mass spectrometers. This workflow provides powerful capabilities to meet the needs of the ICR's demanding research goals, including the assessment of how networks of cancer cells interact with each other and surrounding tissues to metastasize throughout the body, the companies said. Financial details were not released.